Related Experiment Video
Updated: Aug 5, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation
Karel F A Van Damme1,2,3, Pieter Hertens4,5, Dorine Sichien1,2,6
1Laboratory of Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, Belgium.
Impaired A20 function causes inflammation independent of adaptive immunity or the microbiome. Autoantibodies may be a consequence, not a cause, suggesting autoinflammatory disease mechanisms.
Area of Science:
- Immunology
- Genetics
- Microbiology
Background:
- Immune regulation is vital for preventing tissue damage.
- TNFAIP3 (A20) is a key regulator of inflammation; its deficiency causes inflammatory diseases.
- Understanding A20's role in adaptive immunity and the microbiome is crucial for disease pathology.
Purpose of the Study:
- To investigate the role of adaptive immunity and the gut microbiome in pathology arising from impaired A20 function.
- To analyze cell type-specific expression and regulation of TNFAIP3.
- To determine if autoantibodies are causative or consequential in TNFAIP3-associated diseases.
Main Methods:
- Utilized transgenic and gnotobiotic mouse models.
- Examined TNFAIP3 gene expression patterns.
- Assessed the impact of T cells, B cells, and the microbiome on disease.
Main Results:
- Systemic inflammation from TNFAIP3 deficiency in CD11c+ cells occurred independently of B cells, T cells, and autoreactive antibodies.
- The gut microbiome was not essential for disease development.
- TNFAIP3 expression patterns were highly conserved across cell types.
Conclusions:
- TNFAIP3/A20 deficiency leads to autoinflammatory, not autoimmune, pathology.
- Autoantibodies may be a downstream effect rather than a cause of TNFAIP3-associated diseases.
- Findings offer therapeutic insights for TNFAIP3-related inflammatory conditions.
More Related Videos
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Related Concept Videos
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Acute Inflammation III: Local and Systemic Effects
Acute Inflammation I: Inflammatory Response
Inflammatory Bowel Disease II: Ulcerative Colitis
Acute Inflammation II: Cellular Phase